Expertise

Yixiao practice covers mergers & acquisitions as well as corporate law, with a focus on Asia-related cross-border transactions. She regularly advises Asian clients, especially Chinese, Singaporean, Japanese and Korean companies, on German and European law issues. In addition, Yixiao advises German companies on their business activities in Asia.

Vita

Yixiao studied at the University of Heidelberg. She has been a lawyer at Gleiss Lutz since 2018. Yixiao was seconded to top-tier law firms in China and Singapore in 2023.

Yixiao speaks German, English and Chinese (Mandarin).

News
Gleiss Lutz appoints new partners and counsel Article
Conducting Business in China: People’s Republic of China issues First Major Amendment to Arbitration Law in Over Three Decades Article
Gleiss Lutz advises DN Solutions on the acquisition of HELLER Mandate
Gleiss Lutz advises Sunshine Lake Pharma on its listing on Hong Kong Stock Exchange and privatisation of YiChang HEC Mandate
Gleiss Lutz advises CAC Nantong Chemical on acquisition of HELM’s chemical plant protection portfolio in Europe Mandate
Gleiss Lutz advises ruhlamat on sale of its China business to private equity investor Centurium Capital Mandate

All news

Expertise

Yixiao practice covers mergers & acquisitions as well as corporate law, with a focus on Asia-related cross-border transactions. She regularly advises Asian clients, especially Chinese, Singaporean, Japanese and Korean companies, on German and European law issues. In addition, Yixiao advises German companies on their business activities in Asia.

Vita

Yixiao studied at the University of Heidelberg. She has been a lawyer at Gleiss Lutz since 2018. Yixiao was seconded to top-tier law firms in China and Singapore in 2023.

Yixiao speaks German, English and Chinese (Mandarin).

News
Gleiss Lutz appoints new partners and counsel Article
Conducting Business in China: People’s Republic of China issues First Major Amendment to Arbitration Law in Over Three Decades Article
Gleiss Lutz advises DN Solutions on the acquisition of HELLER Mandate
Gleiss Lutz advises Sunshine Lake Pharma on its listing on Hong Kong Stock Exchange and privatisation of YiChang HEC Mandate
Gleiss Lutz advises CAC Nantong Chemical on acquisition of HELM’s chemical plant protection portfolio in Europe Mandate
Gleiss Lutz advises ruhlamat on sale of its China business to private equity investor Centurium Capital Mandate

All news